Caris Life Sciences, Inc. Common Stock (CAI) Stock Forecast & Price Target
Caris Life Sciences, Inc. Common Stock · NASDAQ
$15.63+0.10 (+0.68%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Caris Life Sciences, Inc. Common Stock, 7 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $21.00 to $36.00, a moderate spread. The average target of $27.78 sits 78% above the current $15.63. The rating mix has stayed broadly stable, with Buy-side ratings easing from 9 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.04 next quarter toward $0.36 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy770%
Hold330%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Caris Life Sciences, Inc. Common Stock.
As of Jul, 7 of 10 firms rate CAI a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CAI EPS & revenue forecast
EPS · NEXT QUARTER
$0.04
Range $0.00 – $0.10 · 9 analysts · -50% YoY
Next period, 9 analysts expect Caris Life Sciences, Inc. Common Stock to earn $0.04 a share (range $0.00 – $0.10), versus $0.08 a year earlier. Full-year consensus is $0.13, growing to $0.36 the year after.
REVENUE · NEXT QUARTER
$261.5M
Range $253.7M – $267.0M · 9 analysts · +21% YoY
Revenue is expected to reach $261.5M (range $253.7M – $267.0M), +20.6% year-over-year. Full-year consensus is $1.0B, rising to $1.2B next year.
Top analysts covering Caris Life Sciences, Inc. Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CAI.
#1
KM
Kyle Mikson
Canaccord Genuity · Rank #192
Hold
$22.00+40.8% to target
Overall win rate
35%
+ Follow
#2
David Westenberg
Piper Sandler · Rank #227
Hold
$21.00+34.4% to target
Overall win rate
31%
+ Follow
#3
Patrick Donnelly
Citigroup · Rank #260
Buy
$28.00+79.2% to target
Overall win rate
32%
+ Follow
#4
Vijay Kumar
Evercore ISI Group
Buy
$25.00+60.0% to target
Coverage
—
+ Follow
#5
Mark Massaro
BTIG
Buy
$32.00+104.8% to target
Coverage
—
+ Follow
CAI stock forecast FAQ
What is CAI's average 12-month price target?+
The 9 analysts with a live target average $27.78 for Caris Life Sciences, Inc. Common Stock over the next 12 months, ranging from a $36.00 high to a $21.00 low.
Is CAI stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 7 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CAI?+
The Street-high target is $36.00 (Guggenheim), and the Street-low is $21.00 (Piper Sandler). The average of all 9 active targets is $27.78.
How many Wall Street analysts cover CAI?+
10 analysts have an active rating on Caris Life Sciences, Inc. Common Stock, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering CAI?+
Among analysts who currently cover CAI, Kyle Mikson of Canaccord Genuity has the strongest overall Quantellect track record (Rank #192). Their current call is Hold with a $22.00 target.
What is Caris Life Sciences, Inc. Common Stock's projected EPS for next quarter?+
The consensus estimate is $0.04 per share (range $0.00 – $0.10) across 9 analysts. Full-year EPS is projected at $0.13, rising to $0.36 the following year.
How much revenue is Caris Life Sciences, Inc. Common Stock expected to report next quarter?+
Consensus revenue is $261.5M (range $253.7M – $267.0M). Full-year revenue is projected at $1.0B, growing to $1.2B next year.
Have analysts been upgrading or downgrading CAI lately?+
As of Jul, 7 of 10 firms rate CAI a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CAI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
